切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 15-lipoxygenases - Heme oxygenase - Bcl-2 - Insulin and Insulin-like Receptors

16件产品中的 1-10

页面
每页
清除全部
  1. BDA-366
    B5978 BDA-366
    Target: Bcl-2
    Summary: BCL2 BH4 结构域的选择性拮抗剂
      ≥50.4 mg/mL
      insoluble in H2O
  2. (+)-Apogossypol
    B4902 (+)-Apogossypol
    中文名: 變棉子酚,阿朴棉子酚,变棉子酚
    Target: Bcl-2
    Summary: Bcl-2家族蛋白抑制剂
      ≥16.2 mg/mL
      insoluble in H2O
  3. Zinc protoporphyrin IX
    B6431 Zinc protoporphyrin IX
     2 Citation
    中文名: 锌原卟啉
    Target: Guanylyl Cyclases|Heme oxygenase
    Summary: 血红素加氧酶抑制剂
      ≥20 mg/mL
      insoluble in H2O
  4. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  5. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  6. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  7. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  8. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O
  9. Sabutoclax
    A4199 Sabutoclax
     2 Citation
    Target: Bcl-2|Mcl-1|Bfl-1
    Summary: Pan-Bcl-2抑制剂
      ≥205.6 mg/mL
      insoluble in H2O
  10. Apogossypolone (ApoG2)
    A4200 Apogossypolone (ApoG2)
     2 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2的非肽类小分子抑制剂
      ≥24.55 mg/mL
      insoluble in H2O

16件产品中的 1-10

页面
每页